Indication
Prevention of cardiac ischemia in unstable angina
Prevention of cardiac ischemia in unstable angina refers to the therapeutic mitigation of acute or recurrent myocardial oxygen supply-demand mismatch in patients experiencing unstable angina, an acute coronary syndrome. Read more about Prevention of cardiac ischemia in unstable angina
33 drugs 24 manufacturers
Drugs that treat it
Common Prevention of cardiac ischemia in unstable angina therapies.
ENOXAPARIN (enoxaparin sodium)
ENOXAPARIN (enoxaparin sodium)
ENOXILUV (enoxaparin sodium)
ENOXAPARIN SODIUM
ENOXAPARIN SODIUM
ENOXAPARIN SODIUM
ENOXAPARIN SODIUM
ENOXAPARIN SODIUM
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPrevention of cardiac ischemia in unstable angina refers to the therapeutic mitigation of acute or recurrent myocardial oxygen supply-demand mismatch in patients experiencing unstable angina, an acute coronary syndrome.
This clinical state primarily impacts the cardiovascular system in individuals with underlying coronary artery disease.
Pathophysiologically, it is triggered by atherosclerotic plaque disruption, platelet activation, and transient or incomplete thrombotic coronary occlusion, leading to critical reductions in myocardial perfusion without overt cell necrosis.
Clinically, it manifests as prolonged rest pain, new-onset severe angina, or accelerating crescendo angina, characterized by transient ischemic electrocardiographic alterations such as ST-segment depression or T-wave inversion in the absence of elevated serum cardiac biomarkers.
Preventing ischemia in this setting protects vulnerable myocardium and lowers the risk of progression to acute myocardial infarction or life-threatening arrhythmias.
- nih.gov
Prevention of cardiac ischemia in unstable angina refers to the therapeutic mitigation of acute or recurrent myocardial oxygen supply-demand mismatch in patients experiencing unstable angina, an acute coronary syndrome This clinical state primarily impacts the cardiovascular system in individuals with underlying coronary artery disease Pathophysiologically, it is triggered by atherosclerotic plaque disruption, platelet activation, and transient or incomplete thrombotic coronary occlusion, leadin...
- nih.gov
Prevention of cardiac ischemia in unstable angina refers to the therapeutic mitigation of acute or recurrent myocardial oxygen supply-demand mismatch in patients experiencing unstable angina, an acute coronary syndrome This clinical state primarily impacts the cardiovascular system in individuals with underlying coronary artery disease
- merckmanuals.com
Pathophysiologically, it is triggered by atherosclerotic plaque disruption, platelet activation, and transient or incomplete thrombotic coronary occlusion, leading to critical reductions in myocardial perfusion without overt cell necrosis Clinically, it manifests as prolonged rest pain, new-onset severe angina, or accelerating crescendo angina, characterized by transient ischemic electrocardiographic alterations such as ST-segment depression or T-wave inversion in the absence of elevated serum c...
- nih.gov
Preventing ischemia in this setting protects vulnerable myocardium and lowers the risk of progression to acute myocardial infarction or life-threatening arrhythmias
Personalize your experience
Follow Prevention of cardiac ischemia in unstable angina and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.